142,958 members

Skip to content. | Skip to navigation

News

Treatment for gynaecological cancers approved for cancer drugs fund

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Treatment for gynaecological cancers approved for cancer drugs fund

Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.

This positive recommendation affects adults with BRCA mutation-positive, advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer that has responded to chemotherapy. Currently around 700 women with advanced ovarian cancer are expected to benefit from this new treatment option. More....